Status:
WITHDRAWN
Safety and Efficacy of Intravenous (IV) Dexmedetomidine During Flexible Bronchoscopy and Endobronchial Ultrasound
Lead Sponsor:
Lahey Clinic
Conditions:
Pain
Eligibility:
All Genders
18-85 years
Phase:
PHASE4
Brief Summary
To achieve safe,consistent, continuous sedation using Dexmedetomidine in advaced bronchoscopy procedures that may reduce the need for rapid pain sedative infusion.
Detailed Description
Dexmedetomidine hydrochloride as a single agent produces sedation, pain relief, anxiety redution, stable respiratory rates, and predictable cardiovascular responses. Dexmedetomidine facilitates patien...
Eligibility Criteria
Inclusion
- Adults between the age of 18 and 85
- Adults scheduled for flexible brochoscopy using EUBS (Endobronchial Ultrasound)
Exclusion
- Sever bradycardia (rate \< 50) and / or related bradydysrhymias (e.g. advanced heart block)
- Impaired ventricular functions (EF \<30%)
- Hypovolemia or hypotension (SBP \<90 or MAP \<a55)
- Have GFR less than 15ml/min 1.73m2 or undergoing hemodialysis
- Endstage liver disease.
Key Trial Info
Start Date :
April 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2012
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00691886
Start Date
April 1 2008
End Date
July 1 2012
Last Update
May 10 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lahey Clinic
Burlington, Massachusetts, United States, 01805